SCHEMBL31667541

SCHEMBL31667541

CC1c2cc(N)ccc2C(=O)N1Cc1ccc2[nH]c(=O)oc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IL4I1 Q96RQ9 1/20 0.39
▸ NOS1 P29475 1/20 0.39
▸ PDE10A Q9Y233 1/20 0.34
▸ CREBBP Q92793 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ GRIN1 Q05586 2/20 0.34
▸ GRIN2D O15399 1/20 0.34
▸ GRIN3B O60391 1/20 0.34
▸ GRIN2A Q12879 1/20 0.34
▸ GRIN2B Q13224 1/20 0.34
▸ GRIN2C Q14957 1/20 0.34
▸ GRIN3A Q8TCU5 1/20 0.34
▸ ENPP2 Q13822 1/20 0.34
▸ ATXN2 Q99700 1/20 0.34
▸ PTGDR Q13258 1/20 0.33
▸ PSMB8 P28062 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31667512 0.92 IL4I1 (0.41) IL4I1NOS1PDE10ACREBBPKDM4E
SCHEMBL31667552 0.88 NOS1 (0.51) IL4I1NOS1PDE10ACREBBPKDM4E
SCHEMBL31667589 0.87 NOS1 (0.41) IL4I1NOS1KDM4EALDH1A1ENPP2
SCHEMBL31666978 0.87 GRIN2D (0.41) IL4I1NOS1PDE10ACREBBPKDM4E
SCHEMBL31667528 0.87 IL4I1 (0.39) IL4I1NOS1PDE10ACREBBPKDM4E
SCHEMBL31666950 0.87 IL4I1 (0.39) IL4I1NOS1PDE10ACREBBPKDM4E
SCHEMBL31667564 0.87 IL4I1 (0.39) IL4I1NOS1PDE10ACREBBPKDM4E
SCHEMBL31666976 0.86 IL4I1 (0.46) IL4I1NOS1ALDH1A1GRIN1TSHR
SCHEMBL31667642 0.86 IL4I1 (0.46) IL4I1NOS1ALDH1A1GRIN1TSHR
SCHEMBL31667115 0.86 IL4I1 (0.46) IL4I1NOS1ALDH1A1GRIN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF SIRONAX LTD (KY) 2026-03-19 — — US disclosed
EP-4590674-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd (KY) 2025-07-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF NAMPT, NNMT, SARM1 IL4I1 2872/4885NOS1 2579/4885PDE10A 1264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback